ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy-Reference-Cited by-同舟云学术

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

Published:2019-09-30 Issue:11 Volume:10 Page:2088-2095
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Zhong Jia¹^ORCID,Guo Zihan²,Fan Liping²,Zhao Xinghui¹,Zhao Bingqing²,Cao Zhigang³,Cheng Linlin⁴,Shi Yuanyuan³,Li Xiaoting⁵,Zhang Yanhua²,An Tongtong¹,Wu Meina¹,Wang Yuyan¹,Zhuo Minglei¹^ORCID,Li Jianjie¹,Yang Xue¹^ORCID,Chen Hanxiao¹,Jia Bo¹,Zhao Jun¹

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology‐IPeking University Cancer Hospital & Institute Beijing China

2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of PharmacyPeking University Cancer Hospital & Institute Beijing China

3. Department of Medical OncologyMancheng People's Hospital Baoding China

4. Deportment of Medical OncologyDong'e People's Hospital Liaocheng China

5. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of RadiologyPeking University Cancer Hospital & Institute Beijing China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13184

Reference21 articles.

1. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel

2. The MDR1 (ABCB1) Gene Polymorphism and its Clinical Implications

3. Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population